Reata Pharmaceuticals
Biogen cuts jobs at Reata after $2.95 billion deal for kidney drug rights
Anika Sharma
A mere fortnight after the completion of Biogen’s acquisition of Reata Pharmaceuticals, the newly merged entity is taking a scalpel ...
Sanofi Fails to Secure Reata in Bidding Battle Against Biogen Following Horizon Setback
Anika Sharma
Biogen’s pursuit of Reata, a rare disease company based in Texas, has unveiled a compelling narrative of corporate rivalry and ...
Biogen Outbids Competitor in $7.3 Billion Reata Pharmaceuticals Acquisition Duel
Anika Sharma
In a surprising turn of events, Biogen’s acquisition of Reata Pharmaceuticals for $7.3 billion raised eyebrows among industry observers last ...
